EcoDrugPlus

Toll-Like Receptor 7

Ensembl ID : ENSNGAG00000022269
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll-Like Receptor 8

Ensembl ID : ENSNGAG00000021819
Gene Symbol: TLR8
1 Cross references
200 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSNGAG00000016686
Gene Symbol: TAAR1
3 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSNGAG00000000775
Gene Symbol: TGFBR1
3 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSNGAG00000010202
Gene Symbol: TRPA1
3 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSNGAG00000001739
Gene Symbol: TRPM8
3 Cross references
158 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSNGAG00000017715
Gene Symbol: TSPO
3 Cross references
126 Possible Orthologues:

Transthyretin

Ensembl ID : ENSNGAG00000007113
Gene Symbol: TTR
3 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSNGAG00000013495
Gene Symbol: TPH1
3 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSNGAG00000020443
Gene Symbol: TUBA4A
3 Cross references
224 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSNGAG00000013187
Gene Symbol: LOC108489984
2 Cross references
119 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSNGAG00000007217
Gene Symbol: LOC103733937
2 Cross references
198 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).